chr14-20117594-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004715.5(OR4K17):c.95C>T(p.Ser32Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004715.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR4K17 | NM_001004715.5 | c.95C>T | p.Ser32Leu | missense_variant | 2/2 | ENST00000641386.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR4K17 | ENST00000641386.2 | c.95C>T | p.Ser32Leu | missense_variant | 2/2 | NM_001004715.5 | P1 | ||
OR4K17 | ENST00000641633.2 | c.95C>T | p.Ser32Leu | missense_variant | 3/3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152022Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251236Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135796
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461758Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 727178
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152022Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74262
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2024 | The c.188C>T (p.S63L) alteration is located in exon 1 (coding exon 1) of the OR4K17 gene. This alteration results from a C to T substitution at nucleotide position 188, causing the serine (S) at amino acid position 63 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at